PVigi

Benefit-Risk Assessment for a High-Risk Product

A rigorous benefit-risk assessment that regulators accepted, preserving the marketing authorisation.

✓Marketing Authorisation Maintained
Client
Biotech company
Service
Benefit-risk

The challenge

Emerging safety concerns put a high-risk product's benefit-risk profile under regulatory review. The client had to show that therapeutic benefits outweighed the risks.

Our solution

  • Collection and analysis of clinical and post-marketing data
  • A structured benefit-risk framework
  • Stakeholder engagement
  • Regulatory submission and follow-up

The results

  • Assessment accepted; marketing authorisation kept
  • New risk minimisation measures strengthened the safety profile
  • Clear communication preserved trust among HCPs and patients
  • A proactive benefit-risk process for future products